Imperva (IMPV) Tops Q1 EPS by 12c; Guides FY15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/10/2026
- S&P 500, Dow futures attempt recovery ahead of inflation report
- Brent holds above $100 as tanker attacks dampen hopes for Hormuz traffic recovery
- JPMorgan upgrades Meta on AI models and agents, sees 'meaningful headroom'
- HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review
- This is Morgan Stanley's only preferred sportswear stock
- S&P 500 ends down as oil tops $100 per barrel
- Trump promises $5,000 payout to U.S. adults if Republicans win election
- White House copper tariff plan stalls amid affordability concerns, sources say
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Rogers adds Sportsnet+ content to Xfinity TV packages for free
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Needham & Company Raises PT Sharply as Imperva (IMPV) Raises Guidance
May 8, 2015 6:59 AM EDTNeedham & Company reiterates their Buy rating on Imperva, Inc. (NYSE: IMPV), and raised the price target to $67 (from $48), after a strong, and well above consensuses, March quarter. IMPV reported a revenue of $44.8m (well above $40.5m consensus), and a loss of $0.26 per share was smaller than the $0.38 loss expected. IMPV raised their June quarter consensus to $47-$49m and (0.20) to (0.24), which is... More
Oppenheimer Raises PT After Imperva's (IMPV) Strong 1Q Showing
May 8, 2015 6:38 AM EDTOppenheimer reiterates their Outperform rating on Imperva, Inc. (NYSE: IMPV), and raised their price target to $58 (from $55), after a strong 1Q15.IMPV reported revenue up 42% YoY to $44.8M, which bested Oppenheimer estimates of $40.5M. IMPV also reported a loss per share of $0.26, better than estimated... More

